Overview: Lipase TestIntroduction: The Lipase Test measures lipase to diagnose pancreatitis, causing abdominal pain or nausea. Following 2023 AGA guidelines, it uses biochemical methods for high specificity, supporting pancreatic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected acute or chronic pancreatitis.
Other Names: Lipase Assay, Pancreatitis Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Lipase testing began in the 1980s with pancreatitis research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures lipase to diagnose pancreatitis, guides treatment, and evaluates patients with abdominal pain or nausea.
Test Parameters: 1. Lipase Level
Pretest Condition: Fasting 10-12 hours required. Collect serum or plasma. Report history of abdominal pain, nausea, or pancreatitis symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document abdominal pain, nausea, alcohol use, or family history of pancreatitis. Include current medications, especially pain relievers.
Consent: Written consent required, detailing the tests purpose, pancreatitis implications, and risks of blood collection.
Procedural Considerations: Uses biochemical methods to measure lipase in serum or plasma. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for pancreatitis diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Non-fasting samples may reduce accuracy.
Clinical Significance: Elevated lipase confirms pancreatitis, guiding supportive care or intervention. Normal levels may require amylase or imaging tests.
Specialist Consultation: Consult a gastroenterologist for result interpretation and treatment planning.
Additional Supporting Tests: Amylase, abdominal CT, or pancreatic ultrasound to confirm pancreatitis diagnosis.
Test Limitations: Not specific to pancreatitis; other conditions (e.g., gallstones) may elevate lipase. Clinical correlation is needed.
References: AGA Pancreatitis Guidelines, 2023; Gastroenterology, Forsmark CE, 2022.
